verified SJR 0,742 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Elsevier Inc.

workspace_premium Q2 — Molecular Medicine lock Subscription

Nuclear Medicine and Biology

Nuclear Medicine and Biology is a journal indexed in SJR in Molecular Medicine and Cancer Research with an H index of 100. It has an SJR impact factor of 0,742 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,742.

Nuclear Medicine and Biology focuses its scope in these topics and keywords: imaging, pet, cns, radiosynthesis, preclinical, radiopharmaceutical, radiotracer, characterization, cypb, receptor, ...

ISSN: 0969-8051

Publisher: Elsevier Inc.

Category: Molecular Medicine

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,742 Q2

H-index 100

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,742

H-index

100

Docs (year)

Docs 3y

188

Total refs

2194

Cites 3y

616

Citable 3y

176

Cites/Doc 2y

2.71

Ref/Doc

38.49

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

A retrospect on the discovery of way-100635 and the prospect for improved 5-HT1A receptor PET radioligands

Uptake of 188Re-beta-naphthyl-peptide in cervical carcinoma tumours in athymic mice

Chloramine-T in high-specific-activity radioiodination of antibodies using N-succinimidyl-3-(trimethylstannyl)benzoate as an intermediate

Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter

Characterization of 111In3+ complexes of DTPA amide derivatives: biodistribution and clearance studied by gamma imaging

Characterisation of 67Ga3+ complexes of triaza macrocyclic ligands: biodistribution and clearance studies

Carbon-11-labeled KF21213: a highly selective ligand for mapping CNS adenosine A2A receptors with positron emission tomography

Boronic acid adducts of technetium dioxime (BATO) complexes derived from quinuclidine benzilate (QNB) boronic acid stereoisomers: Syntheses and studies of their binding to the muscarinic acetylcholine receptor

Biodistribution and tumor localization of 111In-labeled unmodified and modified F(ab')2 fragments of human monoclonal IgM (16.88) in a nude mouse model

Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: A comparative animal study

Anomalies in hepatobiliary excretion of technetium-99m-MAG3 preparations

a-Methylene and glycidic acid analogs of IPPA as potential myocardial imaging agents

SHOW MORE ARTICLES

A simplified one-pot synthesis of 9-[(3-[ 18 F]Fluoro-1-hydroxy-2-propoxy)methyl]guanine([ 18 F]FHPG) and 9-(4-[ 18 F]Fluoro-3-hydroxymethylbutyl)guanine ([ 18 F]FHBG) for gene therapy

(-)-N-[11C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D2 receptors

A facile method for the labeling of proteins with zirconium isotopes

A comparative cerebral blood flow study in a baboon model with acetazolamide provocation: 99mTc-HMPAO vs 123I(IMP)

99m Tc-labeling experiments on CCK 4 by a direct method

76Br-labeled monoclonal anti-CEA antibodies for radioimmuno positron emission tomography

188Re- and 99mTc-MAG3 as prosthetic groups for labeling amines and peptides

11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET

[76Br]bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice

[18F]p-MPPF: A Radiolabeled Antagonist for the Study of 5-HT1A Receptors with PET

[11C]A-69024: A potent and selective non-benzazepine radiotracer for in vivo studies of dopamine D1 receptors

[11C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers

FAQs

Nuclear Medicine and Biology has an SJR of 0,742 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Nuclear Medicine and Biology is 25%.

Nuclear Medicine and Biology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Nuclear Medicine and Biology?

What is the APC / publication cost?

What is the acceptance rate?